3D Printing in Compounding: One Pharmacy's Journey and a Discussion for the Industry | CurifyLabs Podcast Series

In Part One of the CurifyLabs Podcast Series, “Trust, Technology & the Future of Compounding,” Pharmacy Podcast Network host Todd Eury is joined by Tenille Davis, PharmD, Chief Advocacy Officer for the Alliance for Pharmacy Compounding (APC), and T.W. Taylor, PharmD, Owner of Williamsburg Drug Co. for a timely conversation about responsible innovation, compliance, and the evolving future of personalized medicine. Together, they explore the state of the compounding industry, opportunities for independent compounding pharmacies, and how pharmacists should evaluate emerging technologies as automation becomes increasingly integrated into pharmacy workflows.

 

The discussion also examines what truly determines compounded dose quality, including the roles of validation, documentation, repeatability, traceability, formulation homogeneity, dispensing accuracy, and pharmacist oversight. Todd and Tenille separate meaningful evidence from marketing claims through “Fact Check: Compounding Edition,” addressing misconceptions such as whether mass uniformity equals content uniformity and whether greater automation automatically means greater quality.

 

The episode sets the foundation for the CurifyLabs series with a central message: the future of compounding depends on bringing technology, evidence, compliance, and pharmacist expertise together to advance personalized patient care responsibly.